Literature DB >> 9029088

IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12.

K Kohno1, J Kataoka, T Ohtsuki, Y Suemoto, I Okamoto, M Usui, M Ikeda, M Kurimoto.   

Abstract

We have previously reported the cloning of a novel cytokine, IFN-gamma-inducing factor (IGIF), which shared some biologic activities with IL-12. In this study, we analyzed the effects of murine IGIF on the activation of T cells, and compared the effects with those of IL-12. IGIF alone had no effect on the activation of T cell lines or Th1 clones, while IGIF increased the IFN-gamma production by antigen-stimulated T cell lines, but had no effect on IL-4 or IL-10 production. As reported with IL-12, IGIF served as a costimulatory factor for Th1 clones stimulated with Ag on B cell APC, immobilized anti-CD3, Con A, or IL-2 to augment IFN-gamma production and to induce IL-2R alpha-chain expression and proliferation of the Th1 clones, whereas IGIF had little or no effect on the IL-4 production and proliferation of Th2 clones stimulated with anti-CD3 or Ag. However, IGIF synergized with IL-12 to further augment the IFN-gamma production of the Th1 clones. Even in the presence of saturated amounts of IL-12, IGIF still augmented the IFN-gamma production and proliferation and enhanced the IL-2R alpha-chain expression of the Th1 clones. In contrast with IL-12, IGIF induced IL-2 production by Ag- or anti-CD3-stimulated Th1 clones. These two findings indicate that IGIF and IL-12 are utilizing different signal transduction pathways. We also found that IGIF as well as IL-12 was endogenously released through interaction between Th1 cells and spleen cell APC in the presence of specific Ag, and that it regulated IFN-gamma production. These results further suggest that IGIF may act as an immunoregulatory factor in the immune response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029088

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  99 in total

1.  IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils.

Authors:  T Yoshimoto; H Tsutsui; K Tominaga; K Hoshino; H Okamura; S Akira; W E Paul; K Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 2.  The critical role of IL-12 and the IL-12R beta 2 subunit in the generation of pathogenic autoreactive Th1 cells.

Authors:  E M Shevach; J T Chang; B M Segal
Journal:  Springer Semin Immunopathol       Date:  1999

Review 3.  Molecular mechanisms in T helper phenotype development.

Authors:  J D Farrar; S H Ranganath; K M Murphy
Journal:  Springer Semin Immunopathol       Date:  1999

4.  Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells.

Authors:  A George-Chandy; K Eriksson; M Lebens; I Nordström; E Schön; J Holmgren
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

5.  Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity.

Authors:  A M Harandi; B Svennerholm; J Holmgren; K Eriksson
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP.

Authors:  Wanda Niedbala; Xiao-Qing Wei; Carol Campbell; Duncan Thomson; Mousa Komai-Koma; Foo Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-25       Impact factor: 11.205

7.  Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice.

Authors:  I Sugawara; H Yamada; H Kaneko; S Mizuno; K Takeda; S Akira
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

8.  Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease.

Authors:  Othmar Ludwiczek; Arthur Kaser; Daniela Novick; Charles A Dinarello; Menachem Rubinstein; Wolfgang Vogel; Herbert Tilg
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

9.  Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis.

Authors:  J-S Lee; C-H Song; C-H Kim; S-J Kong; M-H Shon; H-J Kim; J-K Park; T-H Paik; E-K Jo
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

10.  Anti-CD3 sFv/IL-18 fusion DNA for allergy therapy.

Authors:  Maria Salagianni; David M Kemeny
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.